MedPath

To evaluate the effectiveness of ayurvedic management for heavy menstrual bleeding.

Phase 2
Conditions
Health Condition 1: N920- Excessive and frequent menstruation with regular cycle
Registration Number
CTRI/2021/04/032992
Lead Sponsor
Dr Supriya Subhash Padekar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Age group of patients between 18 to 45 years female.

2. Patient with cyclical excessive Per vaginal bleeding in the form of duration more than 7 days or quantity more than 80ml or both with or without clots during menstrual cycle.

3. Haemoglobin 10 gm% or more.

4. Patient with PID.

5. Patient with uterine fibroid of size less than 12 weeks of pregnancy and patient willing to avoid surgery.

6. Patient with adenomyosis & pelvic endometriosis.

Exclusion Criteria

1. Patients suffering from moderate/severe anaemia (Haemoglobin less than 10 gm%)

2. Suspected cases of spontaneous, threatened or incomplete abortion.

3. Patients with systemic disorders like Thyroid dysfunction, Hypertension, Tuberculosis, Diabetes mellitus.

4. Patient using OC pills.

5. Patient with IUCD (Intra Uterine Contraceptive Device).

6. Genital Malignancy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Stoppage of heavy menstrual bleeding.Timepoint: Baseline 3 visits. <br/ ><br>Each visit with Follow up on 5th,7th,9th day of menses for 3 consecutive menstrual cycles.
Secondary Outcome Measures
NameTimeMethod
To study the effectiveness of Kutajashtak Kwatha and Tranexamic acid on associated symptoms like pain in lower abdomen, passage of clots, odour and staining of menstrual blood, fatigue.Timepoint: Follow up on 5th,7th,9th day of menses for 3 consecutive menstrual cycles.
© Copyright 2025. All Rights Reserved by MedPath